Your browser doesn't support javascript.
Clonal expansion and activation of tissue-resident memory-like Th17 cells expressing GM-CSF in the lungs of severe COVID-19 patients.
Zhao, Yu; Kilian, Christoph; Turner, Jan-Eric; Bosurgi, Lidia; Roedl, Kevin; Bartsch, Patricia; Gnirck, Ann-Christin; Cortesi, Filippo; Schultheiß, Christoph; Hellmig, Malte; Enk, Leon U B; Hausmann, Fabian; Borchers, Alina; Wong, Milagros N; Paust, Hans-Joachim; Siracusa, Francesco; Scheibel, Nicola; Herrmann, Marissa; Rosati, Elisa; Bacher, Petra; Kylies, Dominik; Jarczak, Dominik; Lütgehetmann, Marc; Pfefferle, Susanne; Steurer, Stefan; Zur-Wiesch, Julian Schulze; Puelles, Victor G; Sperhake, Jan-Peter; Addo, Marylyn M; Lohse, Ansgar W; Binder, Mascha; Huber, Samuel; Huber, Tobias B; Kluge, Stefan; Bonn, Stefan; Panzer, Ulf; Gagliani, Nicola; Krebs, Christian F.
  • Zhao Y; III. Department of Medicine, Division of Translational Immunology, University Medical Center Hamburg-Eppendorf, Germany.
  • Kilian C; Institute of Medical Systems Biology, University Medical Center Hamburg-Eppendorf, Germany.
  • Turner JE; Hamburg Center for Translational Immunology (HCTI), University Medical Center Hamburg-Eppendorf, Germany.
  • Bosurgi L; Center for Biomedical AI, University Medical Center Hamburg-Eppendorf, Germany.
  • Roedl K; III. Department of Medicine, Division of Translational Immunology, University Medical Center Hamburg-Eppendorf, Germany.
  • Bartsch P; Hamburg Center for Translational Immunology (HCTI), University Medical Center Hamburg-Eppendorf, Germany.
  • Gnirck AC; III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Germany.
  • Cortesi F; I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Germany.
  • Schultheiß C; Protozoa Immunology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
  • Hellmig M; Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Germany.
  • Enk LUB; III. Department of Medicine, Division of Translational Immunology, University Medical Center Hamburg-Eppendorf, Germany.
  • Hausmann F; Hamburg Center for Translational Immunology (HCTI), University Medical Center Hamburg-Eppendorf, Germany.
  • Borchers A; III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Germany.
  • Wong MN; I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Germany.
  • Paust HJ; Department of Internal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
  • Siracusa F; III. Department of Medicine, Division of Translational Immunology, University Medical Center Hamburg-Eppendorf, Germany.
  • Scheibel N; III. Department of Medicine, Division of Translational Immunology, University Medical Center Hamburg-Eppendorf, Germany.
  • Herrmann M; Institute of Medical Systems Biology, University Medical Center Hamburg-Eppendorf, Germany.
  • Rosati E; III. Department of Medicine, Division of Translational Immunology, University Medical Center Hamburg-Eppendorf, Germany.
  • Bacher P; III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Germany.
  • Kylies D; III. Department of Medicine, Division of Translational Immunology, University Medical Center Hamburg-Eppendorf, Germany.
  • Jarczak D; I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Germany.
  • Lütgehetmann M; I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Germany.
  • Pfefferle S; I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Germany.
  • Steurer S; Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel, Germany.
  • Zur-Wiesch JS; Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel, Germany.
  • Puelles VG; Institute of Immunology, Christian-Albrechts-University of Kiel & UKSH Schleswig-Holstein, Kiel, Germany.
  • Sperhake JP; Hamburg Center for Translational Immunology (HCTI), University Medical Center Hamburg-Eppendorf, Germany.
  • Addo MM; Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Germany.
  • Lohse AW; Institute for Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Germany.
  • Binder M; Institute for Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Germany.
  • Huber S; Institute for Pathology, University Medical Center Hamburg-Eppendorf, Germany.
  • Huber TB; I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Germany.
  • Kluge S; III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Germany.
  • Bonn S; Department of Legal Medicine, University Medical Center Hamburg-Eppendorf, Germany.
  • Panzer U; I. Department of Medicine, Division of Infectious Diseases, University Medical Center Hamburg-Eppendorf, Germany.
  • Gagliani N; German Center for Infection Research, Partner Site Hamburg-Lübeck-Borstel-Riems, Hamburg, Germany.
  • Krebs CF; I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Germany.
Sci Immunol ; 6(56)2021 02 23.
Article in English | MEDLINE | ID: covidwho-1099742
ABSTRACT
Hyperinflammation contributes to lung injury and subsequent acute respiratory distress syndrome (ARDS) with high mortality in patients with severe coronavirus disease 2019 (COVID-19). To understand the underlying mechanisms involved in lung pathology, we investigated the role of the lung-specific immune response. We profiled immune cells in bronchoalveolar lavage fluid and blood collected from COVID-19 patients with severe disease and bacterial pneumonia patients not associated with viral infection. By tracking T cell clones across tissues, we identified clonally expanded tissue-resident memory-like Th17 cells (Trm17 cells) in the lungs even after viral clearance. These Trm17 cells were characterized by a a potentially pathogenic cytokine expression profile of IL17A and CSF2 (GM-CSF). Interactome analysis suggests that Trm17 cells can interact with lung macrophages and cytotoxic CD8+ T cells, which have been associated with disease severity and lung damage. High IL-17A and GM-CSF protein levels in the serum of COVID-19 patients were associated with a more severe clinical course. Collectively, our study suggests that pulmonary Trm17 cells are one potential orchestrator of the hyperinflammation in severe COVID-19.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Granulocyte-Macrophage Colony-Stimulating Factor / Th17 Cells / COVID-19 / Immunologic Memory / Lung Type of study: Prognostic study Topics: Long Covid Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: Sciimmunol.abf6692

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Granulocyte-Macrophage Colony-Stimulating Factor / Th17 Cells / COVID-19 / Immunologic Memory / Lung Type of study: Prognostic study Topics: Long Covid Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: Sciimmunol.abf6692